eess.IVNov 2, 2026

A Novel Conditional Adversarial Diffusion Model for High-Fidelity OCT-to-OCT Image Translation and Precise Anti-VEGF Therapy Response Prediction in Diabetic Macular Edema

Authors: Reza Rasti, Armin Biglari, Sobhan Mohammadi Hafshejani, Alireza Dehghani, Michael J. Allingham, Sina Farsiu

Organizations: Department of Biomedical Engineering, Faculty of Engineering, University of Isfahan, Isfahan, Iran · VIP Lab, Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA · Isfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran · Department of Ophthalmology, Duke University School of Medicine, Durham, NC 27708, USA · 

Abstract

Diabetic macular edema (DME) is a leading cause of severe vision loss among working-age adults. Although intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections currently serve as the first-line therapy for DME, a notable subset of patients fails to respond despite the substantial cost and clinical burden, suggesting they may benefit more from alternative interventions. Automated, noninvasive pre-treatment response assessment could therefore spare non-responders from the current trial-and-error treatment paradigm. In this study, we propose a novel conditional adversarial diffusion framework that synthesizes post-treatment optical coherence tomography (OCT) images from baseline scans, enabling the derivation of each patient's initial response to anti-VEGF therapy. The model was developed with subject-level 5-fold cross-validation on a US cohort (n = 127) and externally validated on an independent Iranian cohort (n = 44). Benchmarked against fourteen baseline and state-of-the-art translation models, the proposed model achieved the best treatment-response prediction performance among the methods evaluated for that task on both cohorts, with balanced accuracies of 85.7% and 93.0% on the US cohort and 85.2% and 95.3% on the external Iranian cohort at the 10% and 20% central subfield thickness reduction thresholds, respectively. Ultimately, this framework offers a decision-support tool to help ophthalmologists anticipate initial anti-VEGF outcomes in DME prior to treatment initiation, toward personalized therapy selection. The source code will be made publicly available upon acceptance.

Explore similar work

CardsList
  1. Response-Aware Multimodal Learning for Post-Treatment Visual Acuity Forecasting

    May 30, 2026Phuoc-Nguyen Bui, Van-Vi Vo, Duc-Tai Le +5Long-Term Time Series ForecastingClinical Outcome Prediction

  2. Automated 2D and 3D Segmentation of AMD and DME Lesions in OCT

    Aug 27, 2026Lucia Sundberg, Zhihao Zhao, M. Ali NasseriOphthalmic Image AnalysisMedical Image Segmentation

  3. OphthaDT: Generative Digital Twins for Forecasting Visual Acuity Trajectories in Ophthalmology

    Jun 20, 2026Pietro Belligoli, Nikita Makarov, Sayedali Shetab Boushehri +3Clinical Outcome PredictionLLM-Based Time Series Forecasting